|
1
|
Keeffe EB: Risk score for development of
HCC: Ready for use in practice? Lancet Oncol. 12:517–519. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furihata T, Sawada T, Kita J, Iso Y, Kato
M, Rokkaku K, Shimoda M and Kubota K: Serum alpha-fetoprotein level
per tumor volume reflects prognosis in patients with hepatocellular
carcinoma after curative hepatectomy. Hepatogastroenterology.
55:1705–1709. 2008.PubMed/NCBI
|
|
3
|
Kütting F, Schubert J, Franklin J, Bowe A,
Hoffmann V, Demir M, Pelc A, Nierhoff D, Töx U and Steffen HM:
Insufficient evidence of benefit regarding mortality due to albumin
substitution in HCC-free cirrhotic patients undergoing large volume
paracentesis. J Gastroenterol Hepatol. 32:327–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sasaki K, Firl DJ, Hashimoto K, Fujiki M,
Diago-Uso T, Quintini C, Eghtesad B, Fung JJ, Aucejo FN and Miller
CM: Development and validation of the HALT-HCC score to predict
mortality in liver transplant recipients with hepatocellular
carcinoma: A retrospective cohort analysis. Lancet Gastroenterol
Hepatol. 2:595–603. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schwarz L, Bubenheim M, Zemour J, Herrero
A, Muscari F, Ayav A, Riboud R, Ducerf C, Regimbeau JM, Tranchart
H, et al: Bleeding recurrence and mortality following
interventional management of spontaneous HCC rupture: Results of a
multicenter European study. World J Surg. 42:225–232. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun LY, Zhang H, Li ZL, Li C, Wang MD and
Yang T: How to predict global trends in HCC mortality if neglecting
more than half the world's cases? J Hepatol. 67:887–888. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao W, Li J, Hu C, Shen J, Liu X, Xu Y and
Ye Z: Symptom clusters and symptom interference of HCC patients
undergoing TACE: A cross-sectional study in China. Support Care
Cancer. 21:475–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen M, Therneau T, Orsini LS and Qiao YL:
Design and rationale of the HCC BRIDGE study in China: A
longitudinal, multicenter cohort trial in hepatocellular carcinoma.
BMC Gastroenterol. 11:532011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li GJ, Harrison TJ, Yang JY, Chen QY, Wang
XY and Fang ZL: Combined core promoter mutations and pre-S deletion
of HBV may not increase the risk of HCC: A geographical
epidemiological study in Guangxi, China. Liver Int. 33:936–943.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng YM, Feng CW, Chen SC and Hsu CD:
Unexpected remission of hepatocellular carcinoma (HCC) with lung
metastasis to the combination therapy of thalidomide and
cyproheptadine: Report of two cases and a preliminary HCC cell line
study. BMJ Case Rep. 2012(bcr2012007180)2012.
|
|
12
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou YQ, Yao Y, Bao YL, Song ZB, Yang C,
Gao XL, Zhang WJ, Sun LG, Yu CL, Huang YX, et al: Juglanthraquinone
C induces intracellular ROS increase and apoptosis by activating
the Akt/Foxo signal pathway in HCC cells. Oxid Med Cell Longev.
2016:49416232016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Huang X, Han J, Zheng W and Ma W:
Extract of Perilla frutescens inhibits tumor proliferation of HCC
via PI3K/AKT signal pathway. Afr J Tradit Complement Altern Med.
10:251–257. 2012.PubMed/NCBI
|
|
15
|
Serru V, Dessen P, Boucheix C and
Rubinstein E: Sequence and expression of seven new tetraspans.
Biochim Biophys Acta. 1478:159–163. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ji ZJ, Wang JL and Chen L: Inhibition of
skin squamous cell carcinoma proliferation and promote apoptosis by
dual silencing of NET-1 and survivin. Oncol Rep. 34:811–822. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu B, Liang X, Jing H, Han X, Sun Y, Guo
C, Liu Y and Cheng W: Effect of NET-1 siRNA conjugated sub-micron
bubble complex combined with low-frequency ultrasound exposure in
gene transfection. Oncotarget. 9:4150–4160. 2017.PubMed/NCBI
|
|
18
|
Zuo Y, Ulu A, Chang JT and Frost JA:
Contributions of the RhoA guanine nucleotide exchange factor Net1
to polyoma middle T antigen-mediated mammary gland tumorigenes and
metastasis. Breast Cancer Res. 20:412018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gabitova G and Burke NJ: Improving
healthcare empowerment through breast cancer patient navigation: A
mixed methods evaluation in a safety-net setting. BMC Health Serv
Res. 14:4072014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wheelock AE, Bock MA, Martin EL, Hwang J,
Ernest ML, Rugo HS, Esserman LJ and Melisko ME: SIS. NET: A
randomized controlled trial evaluating a web-based system for
symptom management after treatment of breast cancer. Cancer.
121:893–899. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen SQ, Li K, Zhu N and Nakao A:
Expression and clinical significance of NET-1 and PCNA in
hepatocellular carcinoma. Med Oncol. 25:341–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang L, Zhu J, Ma Y, Hong C, Xiao S and
Jin L: Neuroepithelial transforming gene 1 functions as a potential
prognostic marker for patients with non-small cell lung cancer. Mol
Med Rep. 12:7439–7446. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun CK, Chua MS, He J and So SK:
Suppression of glypican 3 inhibits growth of hepatocellular
carcinoma cells through up-regulation of TGF-β2. Neoplasia.
13:735–747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bruix J, Sherman M, Llovet JM, Beaugrand
M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M
and Rodés J; EASL Panel of Experts on HCC: Clinical management of
hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL
conference. European association for the study of the liver. J
Hepatol. 35:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu L, Lau SH, Tzang CH, Wen JM, Wang W,
Xie D, Huang M, Wang Y, Wu MC, Huang JF, et al: Association of
Vimentin overexpression and hepatocellular carcinoma metastasis.
Oncogene. 23:298–302. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong
XY, Gu Q, Yao Z and Sun BC: Promotion of hepatocellular carcinoma
metastasis through matrix metalloproteinase activation by
epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med.
15:691–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lauridsen HM, Pellowe AS, Ramanathan A,
Liu R, Miller-Jensen K, McNiff JM, Pober JS and Gonzalez AL: Tumor
necrosis factor-α and IL-17A activation induces pericyte-mediated
basement membrane remodeling in human neutrophilic dermatoses. Am J
Pathol. 187:1893–1906. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma YF, Chen C, Li D, Liu M, Lv ZW, Ji Y
and Xu J: Targeting of interleukin (IL)-17A inhibits PDL1
expression in tumor cells and induces anticancer immunity in an
estrogen receptor-negative murine model of breast cancer.
Oncotarget. 8:7614–7624. 2017.PubMed/NCBI
|
|
29
|
Xu LL, Li ZJ, Niu XL and Deng WM: The
mechanisms of IL-17A on promoting tumor metastasis. Int Rev
Immunol. 36:360–369. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li J, Lau GK, Chen L, Dong SS, Lan HY,
Huang XR, Li Y, Luk JM, Yuan YF and Guan XY: Interleukin 17A
promotes hepatocellular carcinoma metastasis via NF-kB induced
matrix metalloproteinases 2 and 9 expression. PLoS One.
6:e218162011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW,
Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al: MicroRNA-122, a
tumor suppressor microRNA that regulates intrahepatic metastasis of
hepatocellular carcinoma. Hepatology. 49:1571–1582. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ding SJ, Li Y, Shao XX, Zhou H, Zeng R,
Tang ZY and Xia QC: Proteome analysis of hepatocellular carcinoma
cell strains, MHCC97-H and MHCC97-L, with different metastasis
potentials. Proteomics. 4:982–994. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song P, Bao H, Yu Y, Xue Y, Yun D, Zhang
Y, He Y, Liu Y, Liu Q, Lu H, et al: Comprehensive profiling of
metastasis-related proteins in paired hepatocellular carcinoma
cells with different metastasis potentials. Proteomics Clin Appl.
3:841–852. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen L, Wang Z, Zhan X, Li DC, Zhu YY and
Zhu J: Association of NET-1 gene expression with human
hepatocellular carcinoma. Int J Surg Pathol. 15:346–353. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bagci EZ, Vodovotz Y, Billiar TR,
Ermentrout GB and Bahar I: Bistability in apoptosis: Roles of bax,
bcl-2, and mitochondrial permeability transition pores. Biophys J.
90:1546–1559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Prokop A, Wieder T, Sturm I, Essmann F,
Seeger K, Wuchter C, Ludwig WD, Henze G, Dörken B and Daniel PT:
Relapse in childhood acute lymphoblastic leukemia is associated
with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous
caspase-3 processing in vivo. Leukemia. 14:1606–1613. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Manero F, Gautier F, Gallenne T, Cauquil
N, Grée D, Cartron PF, Geneste O, Grée R, Vallette FM and Juin P:
The small organic compound HA14-1 prevents Bcl-2 interaction with
Bax to sensitize malignant glioma cells to induction of cell death.
Cancer Res. 66:2757–2764. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Raisova M, Hossini AM, Eberle J, Riebeling
C, Wieder T, Sturm I, Daniel PT, Orfanos CE and Geilen CC: The
Bax/Bcl-2 ratio determines the susceptibility of human melanoma
cells to CD95/Fas-mediated apoptosis. J Invest Dermatol.
117:333–340. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Del Bufalo D, Biroccio A, Leonetti C and
Zupi G: Bcl-2 overexpression enhances the metastatic potential of a
human breast cancer line. FASEB J. 11:947–953. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mukhopadhyay A, Banerjee S, Stafford LJ,
Xia C, Liu M and Aggarwal BB: Curcumin-induced suppression of cell
proliferation correlates with down-regulation of cyclin D1
expression and CDK4-mediated retinoblastoma protein
phosphorylation. Oncogene. 21:8852–8861. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fu M, Wang C, Li Z, Sakamaki T and Pestell
RG: Minireview: Cyclin D1: Normal and abnormal functions.
Endocrinology. 145:5439–5447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aouacheria A, Cunningham KW, Hardwick JM,
Palková Z, Powers T, Severin FF and Váchová L: Comment on
‘Sterilizing immunity in the lung relies on targeting fungal
apoptosis-like programmed cell death’. Science.
360(eaar6910)2018.PubMed/NCBI
|
|
43
|
Shlezinger N, Irmer H, Dhingra S, Beattie
SR, Cramer RA, Braus GH, Sharon A and Hohl TM: Response to comment
on ‘Sterilizing immunity in the lung relies on targeting fungal
apoptosis-like programmed cell death’. Science.
360(eaas9457)2018.PubMed/NCBI
|
|
44
|
Le DA, Wu Y, Huang Z, Matsushita K,
Plesnila N, Augustinack JC, Hyman BT, Yuan J, Kuida K, Flavell RA
and Moskowitz MA: Caspase activation and neuroprotection in
caspase-3- deficient mice after in vivo cerebral ischemia and in
vitro oxygen glucose deprivation. Proc Natl Acad Sci USA.
99:15188–15193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Richardson-Burns SM, Kominsky DJ and Tyler
KL: Reovirus-induced neuronal apoptosis is mediated by caspase 3
and is associated with the activation of death receptors. J
Neurovirol. 8:365–380. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fu Y, Ye X, Lee M, Rankin G and Chen YC:
Prodelphinidins isolated from Chinese bayberry leaves induces
apoptosis via the p53-dependent signaling pathways in OVCAR-3 human
ovarian cancer cells. Oncol Lett. 13:3210–3218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pidugu VR, Yarla NS, Bishayee A, Kalle AM
and Satya AK: Novel histone deacetylase 8-selective inhibitor
1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer
cells. Apoptosis. 22:1394–1403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhou M, Liu X, Li Z, Huang Q, Li F and Li
CY: Caspase-3 regulates the migration, invasion and metastasis of
colon cancer cells. Int J Cancer. 143:921–930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Persad R, Liu C, Wu TT, Houlihan PS,
Hamilton SR, Diehl AM and Rashid A: Overexpression of caspase-3 in
hepatocellular carcinomas. Mod Pathol. 17:861–867. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Brunet A, Datta SR and Greenberg ME:
Transcription-dependent and -independent control of neuronal
survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol.
11:297–305. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Franke TF, Hornik CP, Segev L, Shostak GA
and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene.
22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Garcia-Echeverria C and Sellers WR: Drug
discovery approaches targeting the PI3K/Akt pathway in cancer.
Oncogene. 27:5511–5526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cao J, Lv W, Wang L, Xu J, Yuan P, Huang
S, He Z and Hu J: Ricolinostat (ACY-1215) suppresses proliferation
and promotes apoptosis in esophageal squamous cell carcinoma via
miR-30d/PI3K/AKT/mTOR and ERK pathways. Cell Death Dis. 9:8172018.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Leng J, Wang Z, Fu CL, Zhang J, Ren S, Hu
JN, Jiang S, Wang YP, Chen C and Li W: NF-κB and AMPK/PI3K/Akt
signaling pathways are involved in the protective effects of
Platycodon grandiflorum saponins against acetaminophen-induced
acute hepatotoxicity in mice. Phytother Res. 32:2235–2246. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang HW, Hu JJ, Fu RQ, Liu X, Zhang YH,
Li J, Liu L, Li YN, Deng Q, Luo QS, et al: Flavonoids inhibit cell
proliferation and induce apoptosis and autophagy through
downregulation of PI3Kgamma mediated PI3K/AKT/mTOR/p70S6K/ULK
signaling pathway in human breast cancer cells. Sci Rep.
8:112552018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Saxena NK, Sharma D, Ding X, Lin S, Marra
F, Merlin D and Anania FA: Concomitant activation of the JAK/STAT,
PI3K/AKT, and ERK signaling is involved in leptin-mediated
promotion of invasion and migration of hepatocellular carcinoma
cells. Cancer Res. 67:2497–2507. 2007. View Article : Google Scholar : PubMed/NCBI
|
